Codem, Immune Checkpoint Inhibitor Theme Rises 6.05%

On the 19th, the immuno-oncology theme rose by 3.92% compared to the previous day, showing strong performance, while Codem, a related stock drawing attention, surged by 6.05% compared to the previous day. Codem is known as a semiconductor and display manufacturing equipment company.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Codem’s quant financial score was 9.49 points, ranking 15th in the quant financial ranking within the immuno-oncology theme. This can be interpreted as Codem having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.